Boston Scientific Corp., 10% Owner at Pulmonx Corp (LUNG), sold 2,700,000 shares at $40.80 ($110.2M) on 2021-03-30, disclosed to the SEC on 2021-04-01.
Open-market sale of $110.2M LUNG by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.80 | 1,350,000 | $55.1M | 50.0% |
| 2 | $40.80 | 1,350,000 | $55.1M | 50.0% |
| Total | $40.80 avg | 2,700,000 | $110.2M | 100% |
| Filing → |
| IMRX | SELL | 2008-09-19 | $400K | — | Filing → |
| CYBX | SELL | 2007-10-05 | $48.6M | — | Filing → |
| NSTR | SELL | 2007-07-26 | $32.5M | — | Filing → |